Kathy Lee-Sepsick understands something most people overlook: women have been told to accept medical solutions that don't work for them. And she decided to change that.

As President and CEO of Femisys, Kathy has spent nearly 30 years in medical technology and holds over 200 global patents. But her real impact? She's created non-surgical solutions for permanent birth control and infertility treatment—innovations that didn't exist before. Solutions that are changing what's possible for millions of women.

In this powerful conversation with host Jodie O'Brien, Kathy reveals the 22-year journey from idea to innovation, the systemic barriers to women's health funding, and what it takes to persist when everyone questions whether it's possible.

This episode isn't about luck or inspiration. It's about science, strategy, and a woman who decided that women deserved better options than surgery and incisions. It's about the real cost of underfunding women's health and why innovation stalls when investors don't understand the market. It's about infertility—a shared issue that affects both men and women, but has been treated as a woman's failure.

Kathy shares:

• How she went from biochemistry to medical technology innovation
• Why she left a successful career to focus on women's reproductive health
• The systemic reasons investors don't fund women's health innovations
• Why infertility is actually a male-female issue—not what most people think
• The science behind her breakthrough technologies and why they're different
• What it really takes to raise capital for women's health in a male-dominated investor landscape
• How she navigated FDA approval, regulatory hurdles, and doubt over 10 years
• Why there's hope now for women struggling with infertility
• Her message to young women with big ideas: Do the time. Do the work. Keep pushing.

What makes this episode different: Kathy doesn't offer motivation without substance. She offers proof through her patents, her persistence, and the technologies that are now giving women options that didn't exist before. She speaks to the business realities of innovation in women's health while honoring the emotional weight of infertility and reproductive choices.

This is for anyone who's struggled with infertility and felt alone. For women with ideas they're afraid to pursue. For people wondering why women's health has been overlooked for so long. For anyone ready to understand that innovation requires time, expertise, and a refusal to skip steps.